Skip to main content
UNH
NYSE Life Sciences

UnitedHealthcare Cuts Two-Thirds of Pediatric Prior Authorization Requirements

Reported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$381.81
Mkt Cap
$347.392B
52W Low
$234.6
52W High
$404.15
Market data snapshot near publication time

Summary

UnitedHealthcare is eliminating nearly two-thirds of prior authorization requirements for pediatric care, specifically for members under 18, across its commercial and Medicaid plans. This follows a broader announcement on April 20th regarding significant operational policy changes. This move aims to reduce administrative burden for providers and improve access to care, potentially enhancing the company's public image and addressing regulatory scrutiny. The company is continuing its review of pediatric prior authorization requirements to identify further services for removal.

At the time of this announcement, UNH was trading at $381.81 on NYSE in the Life Sciences sector, with a market capitalization of approximately $347.4B. The 52-week trading range was $234.60 to $404.15. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

UNH - Latest Insights

UNH
May 29, 2026, 10:04 AM EDT
Source: Reuters
Importance Score:
7
UNH
May 29, 2026, 8:33 AM EDT
Source: Reuters
Importance Score:
7
UNH
May 18, 2026, 8:58 AM EDT
Source: Reuters
Importance Score:
7
UNH
May 05, 2026, 4:38 PM EDT
Filing Type: 10-Q
Importance Score:
7
UNH
Apr 24, 2026, 9:05 AM EDT
Source: Reuters
Importance Score:
8
UNH
Apr 21, 2026, 6:41 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
UNH
Apr 21, 2026, 5:03 PM EDT
Filing Type: DEF 14A
Importance Score:
7
UNH
Apr 21, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
9
UNH
Apr 21, 2026, 5:55 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
UNH
Apr 21, 2026, 12:14 AM EDT
Source: dpa-AFX
Importance Score:
7